[go: up one dir, main page]

IT1191608B - Composizione farmaceutica e forme farmaceutiche che la contengono - Google Patents

Composizione farmaceutica e forme farmaceutiche che la contengono

Info

Publication number
IT1191608B
IT1191608B IT19353/85A IT1935385A IT1191608B IT 1191608 B IT1191608 B IT 1191608B IT 19353/85 A IT19353/85 A IT 19353/85A IT 1935385 A IT1935385 A IT 1935385A IT 1191608 B IT1191608 B IT 1191608B
Authority
IT
Italy
Prior art keywords
pharmaceutical
contain
forms
pharmaceutical composition
composition
Prior art date
Application number
IT19353/85A
Other languages
English (en)
Other versions
IT8519353A0 (it
Inventor
Franco Pozzi
Antonio Longo
Angelo Carenzi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT19353/85A priority Critical patent/IT1191608B/it
Publication of IT8519353A0 publication Critical patent/IT8519353A0/it
Priority to EP86900772A priority patent/EP0211023B1/en
Priority to JP61500886A priority patent/JPS62501908A/ja
Priority to PCT/EP1986/000046 priority patent/WO1986004503A1/en
Priority to AT86900772T priority patent/ATE59142T1/de
Priority to US06/925,626 priority patent/US4869900A/en
Priority to DE8686900772T priority patent/DE3676248D1/de
Application granted granted Critical
Publication of IT1191608B publication Critical patent/IT1191608B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
IT19353/85A 1985-02-01 1985-02-01 Composizione farmaceutica e forme farmaceutiche che la contengono IT1191608B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT19353/85A IT1191608B (it) 1985-02-01 1985-02-01 Composizione farmaceutica e forme farmaceutiche che la contengono
EP86900772A EP0211023B1 (en) 1985-02-01 1986-01-31 Pharmaceutical composition containing ubidecarenone
JP61500886A JPS62501908A (ja) 1985-02-01 1986-01-31 薬理的組成物及びそれを含有する薬理的製剤
PCT/EP1986/000046 WO1986004503A1 (en) 1985-02-01 1986-01-31 Pharmaceutical composition containing ubidecarenone
AT86900772T ATE59142T1 (de) 1985-02-01 1986-01-31 Ubidecarenon enthaltende arzneimittel.
US06/925,626 US4869900A (en) 1985-02-01 1986-01-31 Pharamaceutical composition containing ubidecarenone
DE8686900772T DE3676248D1 (de) 1985-02-01 1986-01-31 Ubidecarenon enthaltende arzneimittel.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19353/85A IT1191608B (it) 1985-02-01 1985-02-01 Composizione farmaceutica e forme farmaceutiche che la contengono

Publications (2)

Publication Number Publication Date
IT8519353A0 IT8519353A0 (it) 1985-02-01
IT1191608B true IT1191608B (it) 1988-03-23

Family

ID=11156982

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19353/85A IT1191608B (it) 1985-02-01 1985-02-01 Composizione farmaceutica e forme farmaceutiche che la contengono

Country Status (6)

Country Link
US (1) US4869900A (it)
EP (1) EP0211023B1 (it)
JP (1) JPS62501908A (it)
DE (1) DE3676248D1 (it)
IT (1) IT1191608B (it)
WO (1) WO1986004503A1 (it)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
CH668553A5 (de) * 1987-02-02 1989-01-13 Mepha Ag Arzneimittel mit verzoegerter wirkstofffreisetzung.
CH680072A5 (it) * 1989-10-27 1992-06-15 Nestle Sa
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
AU5832794A (en) * 1993-01-06 1994-08-15 T.S. Consult Aps Medium comprising a pharmacological/biological active substance
ES2074395B1 (es) * 1993-02-25 1996-03-01 Lifepharma Srl Composicion farmaceutica o dietetica de elevada actividad antioxidante en las patologias cardiovasculares y/o hepaticas.
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
DE69431959T2 (de) * 1993-10-15 2003-11-06 Cytrx Corp Therapeutische abgabesysteme und verfahren für ihre verwendung
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
CN1216636C (zh) 1996-08-30 2005-08-31 派普泰克有限公司 肽缓释组合物
WO1998056368A1 (en) * 1997-06-09 1998-12-17 Board Of Regents, The University Of Texas System Superiority of formulations containing coenzyme q10 in coconut oil
US6503483B2 (en) * 1997-06-12 2003-01-07 C.S. Bioscience, Inc. Dental formulation
DE19753108A1 (de) * 1997-11-29 1999-08-05 Wella Ag Mittel zur Erhöhung der Formbarkeit und des Glanzes von Haaren
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
US6200550B1 (en) 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
DE19859045A1 (de) * 1998-12-21 2000-06-29 Fresenius Pharma Austria Gmbh Emulsion vom Typ Öl in Wasser mit Schutzwirkung gegen Peroxidationsschäden an menschlichen Organen, deren Herstellung und Verwendung
US6740338B1 (en) 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
GB0029843D0 (en) * 2000-12-07 2001-01-24 Univ Belfast Drug delivery system
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
JP4567945B2 (ja) * 2003-01-17 2010-10-27 太陽化学株式会社 ユビデカレノン製剤
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
US20050074444A1 (en) * 2003-10-01 2005-04-07 Papas Andreas M. Coenzyme Q10 treatment for cystic fibrosis
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
AU2006235633A1 (en) * 2005-04-14 2006-10-19 Jarrow Formulas, Inc. Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration
US8252326B2 (en) * 2005-06-01 2012-08-28 Catalent Australia Pty Ltd. Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
KR100754953B1 (ko) 2005-09-14 2007-09-04 주식회사 대웅 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법
KR100859781B1 (ko) 2007-03-26 2008-09-24 (주)미토콘 유비데카레논-함유 약학 조성물
KR100790957B1 (ko) 2007-09-06 2008-01-04 영남대학교 산학협력단 코-엔자임 ｑ 경구용 고형제제 조성물
EP2544663B1 (en) 2010-03-12 2018-01-03 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
CN110200910B (zh) * 2019-06-17 2022-04-19 北京中超海奇科技有限公司 一种辅酶q10透明水分散液的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525350A (en) * 1975-02-20 1985-06-25 The New England Institute, Inc. Methods of stimulating host defense system with coenzymes Q4 to Q.sub.1
JPS597685B2 (ja) * 1978-10-06 1984-02-20 理研ビタミン株式会社 ビタミン製剤の製造法
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
JPS5665817A (en) * 1979-10-31 1981-06-03 Teikoku Chem Ind Corp Ltd Vitamin k injection
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
JPS601124A (ja) * 1983-06-16 1985-01-07 Eisai Co Ltd ユビデカレノン含有リポソ−ム被覆体
JPS6025918A (ja) * 1983-07-25 1985-02-08 Ajinomoto Co Inc 脂溶性薬物含有水性液
EP0366156B1 (de) * 1984-01-28 1995-01-11 Roshdy Dr. Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
JPS61172814A (ja) * 1985-01-25 1986-08-04 Ss Pharmaceut Co Ltd 安定な低溶血性ビタミンｅ注射液

Also Published As

Publication number Publication date
WO1986004503A1 (en) 1986-08-14
EP0211023B1 (en) 1990-12-19
JPS62501908A (ja) 1987-07-30
IT8519353A0 (it) 1985-02-01
DE3676248D1 (de) 1991-01-31
US4869900A (en) 1989-09-26
EP0211023A1 (en) 1987-02-25

Similar Documents

Publication Publication Date Title
IT1191608B (it) Composizione farmaceutica e forme farmaceutiche che la contengono
BR1100036A (pt) Composto e composição farmacêutica
DK330287A (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
MX163529B (es) Composicion quimicoluminiscente
IT1197061B (it) Composizioni farmaceutiche ad azione vasodilatatrice e antianossica
IT1209615B (it) Composizione farmaceutica
IT1213453B (it) Composizione farmaceutica.
IT1191639B (it) Composizione farmaceutica contenente fosfocreatina e metodo per preparla
DK652687D0 (da) Farmaceutisk sammensaetning omfattende azumolen
IT1197811B (it) 2h-benzotriazoli 5-superiore alchil-sostituiti e composizioni stabilizzate
IT1200467B (it) Formulazione farmaceutica
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
IT8667509A0 (it) Composizione alghicida e erbicida
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
BR1100961A (pt) Composto e composição farmacêutica
BR6500021U (pt) Manta salutar
IT8521323A0 (it) Xantinilmetil-tiazolidine e composizioni farmaceutiche che le contengono.
BR6500407U (pt) Composicao medicinal
SE8400086D0 (sv) Farmaceutisk komposition
SE8500731D0 (sv) Farmaceutisk eller kosmetisk komposition
IT8520272A0 (it) Composizione farmaceutica.
ES286286Y (es) Manta perfeccionada
IT1213197B (it) Xantinilmetil-tiazolidine e composizioni farmaceutiche che le contengono.